Report overview
This report contains market size and forecasts of Prostate Cancer Drugs in global, including the following market information:
Global Prostate Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prostate Cancer Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Prostate Cancer Drugs companies in 2021 (%)
The global Prostate Cancer Drugs market was valued at 6493 million in 2021 and is projected to reach US$ 9906.2 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Drugs include AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, by Type, 2021 (%)
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Global Prostate Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Others
Global Prostate Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prostate Cancer Drugs revenues share in global market, 2021 (%)
Key companies Prostate Cancer Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Prostate Cancer Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
